Skip to main content
. 2018 Mar 6;67(4):541–548. doi: 10.1093/cid/ciy153

Table 1.

Patient Characteristics (N = 199)

Characteristic No. (%)
Age at diagnosis, y, median (range) 6.4 (0.5–18.4)
Age at diagnosis, y, No. (%)
 <1.5 9 (5)
 1.5–4 72 (36)
 5–9 65 (33)
 ≥10 53 (27)
Sex, No. (%)
 Male 118 (59)
 Female 81 (41)
Race, No. (%)
 Black 28 (14)
 White 158 (79)
 Other 13 (7)
Acute lymphoblastic leukemia risk level at induction
 Low 106 (53)
 Standard 81 (41)
 High 12 (6)
Stool samples, No. (%) 406
 Baseline before induction 112 (28)
 After induction completion 97 (24)
 Postconsolidation at reinduction I initiation 107 (26)
 Postreinduction at reinduction II initiation 90 (22)
Patients with infection outcomes, No. (%)
 Bloodstream infectionsa 26 (13)
 Febrile neutropenia 122 (61)
 Diarrheal illnessb 73 (37)
 No infection outcomec 42 (21)

aEtiologic agents of bloodstream infections included coagulase-negative staphylococci (7 episodes), Escherichia coli (3), Enterococcus species (3, all susceptible to vancomycin), Staphylococcus aureus (3), Streptococcus pneumoniae (3), Rothia mucilaginosa (2), Neisseria polysaccharea (2), Stenotrophomonas maltophilia (1), Enterobacter cloacae (1), Micrococcus species (1), Bacillus cereus (1), Pseudomonas aeruginosa (1), Streptococcus salivarius (1), Capnocytophaga sputigena (1), and Burkholderia cepacia (1).

bEtiologies included Clostridium difficile (45 episodes), rotavirus (5), norovirus (5), adenovirus (4), and Cryptosporidium (2).

cNo fever, bacteremia, febrile neutropenia, or diarrheal illness.